By contrast, ACT+MS-275 treatment demonstrated drastically higher levels of cleaved caspase 3 relative to ACT alone, suggesting that MS-275 synergized with ACT to drive tumor apoptosis. This evidence concerns the gene CASP3 and neoplasm.